Tutino, Vincent M. http://orcid.org/0000-0002-1331-2551
Rajabzadeh-Oghaz, Hamidreza
Veeturi, Sricharan S.
Poppenberg, Kerry E.
Waqas, Muhammad
Mandelbaum, Max
Liaw, Nicholas
Siddiqui, Adnan H.
Meng, Hui
Kolega, John
Article History
Received: 15 October 2020
Revised: 5 January 2021
Accepted: 18 January 2021
First Online: 26 January 2021
Declarations
:
: Not applicable.
: Not applicable.
: VMT—Principal investigator: National Science Foundation Award No. 1746694, NIH NINDS award R43 NS115314-0, Clinical and Translational Science Institute grant. Co-founder: Neurovascular Diagnostics, Inc.AHS—Financial Interest/Investor/Stock Options/Ownership: Amnis Therapeutics, Apama Medical, BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Health, Cerebrotech Medical Systems, Inc, Claret Medical, Cognition Medical, Endostream Medical, Ltd, Imperative Care, International Medical Distribution Partners, Rebound Therapeutics Corp., Silk Road Medical, StimMed, Synchron, Three Rivers Medical, Inc., Viseon Spine, Inc. Consultant/Advisory Board: Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA, Inc., Cerebrotech Medical Systems, Inc., Cerenovus, Claret Medical, Corindus, Inc., Endostream Medical, Ltd, Guidepoint Global Consulting, Imperative Care, Integra, Medtronic, Micro- Vention, Northwest University—DSMB Chair for HEAT Trial, Penumbra, Rapid Medical, Rebound Therapeutics Corp., Silk Road Medical, StimMed, Stryker, Three Rivers Medical, Inc., VasSol, W.L. Gore & Associates. National PI/Steering Committees: Cerenovus LARGE Trial and ARISE II Trial, Medtronic SWIFT PRIME and SWIFT DIRECT Trials, MicroVention FRED Trial & CONFIDENCE Study, MUSC POSITIVE Trial, Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial. Principal investigator: Cummings Foundation grant.HM—Principal investigator NIH grant R01NS064592 and NIH grant R01NS091075. Co-founder: Neurovascular Diagnostics, Inc.HR-O, SSV, KEP, MW, MM, NL, JK declare no competing interests.